Stiles Financial Services Inc increased its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 12.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,033 shares of the biopharmaceutical company’s stock after purchasing an additional 334 shares during the […]